Article Details
Retrieved on: 2023-10-10 00:03:10
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Morgan Stanley dropped their price objective on Alnylam Pharmaceuticals from $210.00 to $175.00 in a research note on Monday.
Article found on: www.marketbeat.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here